Does edoxaban improve outcomes in patients with device-detected atrial high-rate episodes ≥24 h and stroke risk factors?
This hypothesis-generating analysis suggests no interaction between AHRE duration and the effect of anticoagulation therapy in patients with device-detected AHRE.
This hypothesis-generating analysis does not find an interaction between AHRE duration and anticoagulation therapy in patients with device-detected AHRE and stroke risk factors. Further research is needed to identify patients with long AHRE at high stroke risk.
Becher et al. (Sun,) studied this question.